Breaking Down Shenzhen Transsion Holdings Co., Ltd. Financial Health: Key Insights for Investors

Breaking Down Shenzhen Transsion Holdings Co., Ltd. Financial Health: Key Insights for Investors

CN | Technology | Communication Equipment | SHH

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

As investors scrutinize Shenzhen Transsion Holdings (688036.SS), the numbers tell a mixed but compelling story: revenue plunged to 13.004 billion yuan in Q1 2025 (down 25.45% year-over-year) yet rebounded to 20.47 billion yuan in Q3 2025 (+22.60% YoY) while nine‑month revenue sits at 49.54 billion yuan versus 51.25 billion a year earlier; profitability shows strain-Q1 net income attributable to shareholders was just 0.49 billion yuan (a 69.87% decline) and Q1 net margin compressed to 3.77% from 12.65%-even as trailing twelve‑month ROE is a robust 21.81% and ROA 5.31%; liquidity and valuation metrics add nuance: total cash was 23.97 billion yuan (cash per share 21.02 yuan), market capitalization is 79.44 billion yuan with a share price of 69.01 yuan (Dec 12, 2025), trailing and forward P/Es stand at 19.38 and 12.85 respectively, enterprise‑value/EBITDA sits at 16.75, and analysts favor the stock with 26 buy and 2 hold recommendations amid forecasts of 77.5 billion yuan revenue in 2025 and 6.4 billion yuan projected net profit for 2025-read on to weigh how these figures map to risk, liquidity, debt ratios and growth across Transsion's multi‑brand, emerging‑market strategy.

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) - Revenue Analysis

Shenzhen Transsion reported mixed topline performance across 2024-2025 with uneven quarterly recoveries but a nearly flat nine‑month revenue base year‑over‑year.
  • Q1 2025 revenue: 13.004 billion yuan (down 25.45% YoY)
  • Q3 2025 revenue: 20.47 billion yuan (up 22.60% YoY)
  • 9M ended Sep 30, 2025: ~49.54 billion yuan (vs. 51.25 billion yuan in 9M 2024)
  • FY 2024 revenue: 68.72 billion yuan (up 10.31% vs. 2023)
  • Revenue per employee: ~3.37 million yuan (19,870 employees)
  • Price-to-Sales (P/S) ratio: 1.17
Period Revenue (billion yuan) YoY % Change
Q1 2025 13.004 -25.45%
Q3 2025 20.47 +22.60%
9M 2025 (ending Sep 30) 49.54 -3.35% vs 9M 2024
9M 2024 (for comparison) 51.25 -
FY 2024 68.72 +10.31%
Employees 19,870 Revenue per employee: 3.37 million yuan
Market multiple P/S = 1.17 -
  • Quarterly dynamics: Q1 2025 showed a sharp decline, with partial recovery by Q3 2025 producing strong YoY growth in that quarter but not fully offsetting earlier weakness.
  • Nine‑month trend: 9M 2025 revenue (~49.54 billion) is slightly below the prior‑year 9M (51.25 billion), indicating lagging or uneven recovery across markets/products.
  • Efficiency and valuation: revenue per employee (~3.37M yuan) reflects operating scale; P/S of 1.17 signals modest market valuation relative to sales.
  • Investor considerations: monitor sequential quarterly momentum, margin trends, geographic/product mix, and inventory/channel adjustments that could drive FY 2025 outcomes.
Exploring Shenzhen Transsion Holdings Co., Ltd. Investor Profile: Who's Buying and Why?

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) - Profitability Metrics

Recent reported results point to a material weakening in profit generation for Shenzhen Transsion Holdings Co., Ltd. across both quarterly and year-to-date measures. Key headline figures from the company's latest disclosures include sharp YoY declines in quarterly net income and EPS, alongside muted margins and modest operating returns on assets and equity.

  • Q1 2025 net income attributable to shareholders: 0.49 billion yuan (down 69.87% YoY).
  • Q1 2025 net profit margin: 3.77% (vs. 12.65% in Q1 2024).
  • Basic EPS Q1 2025: 0.43 yuan (down 70.14% YoY).
  • Nine months ended Sep 30, 2025 net income: 2.15 billion yuan (vs. 3.90 billion yuan for same period 2024).
  • Trailing twelve months (TTM) ROA: 5.31%; ROE: 21.81%.
  • TTM operating margin: 3.26%.
Metric Value Comparator / Note
Net income (Q1 2025) 0.49 billion CNY -69.87% YoY
Net profit margin (Q1 2025) 3.77% Q1 2024: 12.65%
Basic EPS (Q1 2025) 0.43 CNY -70.14% YoY
Net income (9M ended Sep 30, 2025) 2.15 billion CNY 9M 2024: 3.90 billion CNY
ROA (TTM) 5.31% Trailing twelve months
ROE (TTM) 21.81% Trailing twelve months
Operating margin (TTM) 3.26% Reflects operational efficiency

Investor-focused takeaways and considerations:

  • Profitability contraction: steep YoY drops in Q1 net income and EPS signal margin pressure and/or one-off items reducing headline profits.
  • Margin compression: net profit margin falling from 12.65% to 3.77% in a year highlights either rising costs, lower gross margins, pricing pressure, or higher non-operating charges.
  • Scale vs. efficiency: TTM ROE of 21.81% suggests equity returns remain elevated relative to ROA (5.31%), indicating leverage and capital structure still contribute materially to shareholder returns.
  • Operating efficiency muted: a TTM operating margin of 3.26% underscores tight operational profitability despite previously stronger margins.
  • Year-to-date decline: 9M net income falling to 2.15 billion CNY from 3.90 billion CNY in the prior year signals the deterioration is persistent through the year, not limited to a single quarter.

For additional context on shareholder composition, recent filings, and how these profitability metrics interact with market positioning, see: Exploring Shenzhen Transsion Holdings Co., Ltd. Investor Profile: Who's Buying and Why?

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) - Debt vs. Equity Structure

Key balance-sheet and valuation metrics as of March 31, 2025 provide a snapshot of Shenzhen Transsion Holdings Co., Ltd.'s capital structure, liquidity and market valuation. Below are the primary figures investors should consider when assessing financial health and leverage sensitivity.

  • Total debt-to-equity ratio: 13.64 - reflects a moderate reliance on debt financing versus shareholders' equity.
  • Total cash: ¥23.97 billion - a strong liquidity buffer for operations, working capital and potential strategic uses.
  • Book value per share: ¥18.21 - indicates net asset value attributable to each outstanding share.
  • Enterprise value / Revenue (EV/Revenue): 1.09 - market valuation relative to top-line sales.
  • Enterprise value / EBITDA (EV/EBITDA): 16.75 - market valuation relative to operating earnings.
  • Current ratio: 1.69 - capacity to meet short-term obligations with short-term assets.
Metric Value Interpretation
Debt-to-Equity Ratio 13.64 Moderate leverage; equity base significantly larger than debt.
Total Cash ¥23.97 billion Ample liquidity for near-term needs and flexibility.
Book Value per Share ¥18.21 Underlying net asset value per share.
EV / Revenue 1.09 Enterprise value roughly equals annual revenue.
EV / EBITDA 16.75 Market assigns a premium to operating earnings.
Current Ratio 1.69 Comfortable short-term liquidity position.

Practical implications for investors:

  • With a debt-to-equity of 13.64 and substantial cash reserves (¥23.97B), the company shows low financial stress from leverage while retaining flexibility for investment or shareholder returns.
  • EV/EBITDA of 16.75 suggests market expectations for growth or margin stability; compare to peers for relative valuation context.
  • Current ratio of 1.69 reduces near-term liquidity risk, but monitor working capital trends and seasonal cash flow swings.
  • Book value per share (¥18.21) offers a baseline for assessing price-to-book multiples versus market price.

For strategic context and corporate direction, see: Mission Statement, Vision, & Core Values (2026) of Shenzhen Transsion Holdings Co., Ltd.

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) - Liquidity and Solvency

Key liquidity and solvency metrics for Shenzhen Transsion Holdings Co., Ltd. reflect mixed cash-generation trends and margin pressure amid competitive and supply-chain headwinds.

  • Operating cash flow (TTM): 2.22 billion yuan - positive overall cash generation from operations.
  • Net cash flow from operating activities (Q1 2025): -0.741 billion yuan, vs. -0.108 billion yuan in Q1 2024 - a significant deterioration year-over-year.
  • Cash and cash equivalents (end Q1 2025): 13.697 billion yuan, up 2.387 billion yuan from the beginning of the year.
  • Net profit margin (Q1 2025): 3.77%, down from 12.65% in Q1 2024 - substantial margin compression.
  • Gross margin (Q1 2025): 19.97% - indicating cost and pricing pressure.
  • Total cash per share: 21.02 yuan - a per-share view of cash reserves.
Metric Value Period YoY / Change
Operating Cash Flow (TTM) 2.22 billion yuan Trailing 12 months -
Net Cash Flow from Operating Activities -0.741 billion yuan Q1 2025 From -0.108 billion yuan in Q1 2024
Cash & Cash Equivalents 13.697 billion yuan End Q1 2025 +2.387 billion yuan vs. beginning of year
Net Profit Margin 3.77% Q1 2025 Down from 12.65% in Q1 2024
Gross Margin 19.97% Q1 2025 Reflects market & supply-chain pressure
Total Cash per Share 21.02 yuan End Q1 2025 -

Investor considerations include the contrast between positive trailing operating cash flow (2.22bn yuan) and the sharp Q1 2025 operating cash outflow (-0.741bn yuan), alongside compressed profitability (net margin 3.77%, gross margin 19.97%) despite a sizable cash balance (13.697bn yuan; 21.02 yuan per share). For company background and broader context, see Shenzhen Transsion Holdings Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) - Valuation Analysis

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) presents a valuation profile that suggests the market prices in meaningful near-term earnings growth while valuing its net assets and operating cash generation at moderate premiums relative to peers.
  • Trailing twelve months (TTM) P/E: 19.38 - current earnings imply a mid- to high-teens multiple.
  • Forward P/E: 12.85 - market consensus expects earnings to rise, compressing the forward multiple versus TTM.
  • Price-to-Book (P/B): 4.10 - shareholders are paying ~4.1x reported book value.
  • Enterprise Value / Revenue (EV/Rev): 1.09 - EV roughly equals annual revenue, indicating a ~1x revenue multiple.
  • Enterprise Value / EBITDA (EV/EBITDA): 16.75 - valuation on operating cash profit sits near the mid-teens.
  • Market Capitalization: ¥79.44 billion - based on share price of ¥69.01 as of 12-Dec-2025.
  • Share Price (12-Dec-2025): ¥69.01.
  • Beta: 1.02 - volatility roughly in line with the broader market.
Metric Value Implication
TTM P/E 19.38 Reflects current earnings multiple; higher than forward P/E signals expected EPS growth.
Forward P/E 12.85 Market-implied earnings growth over the next 12 months.
P/B 4.10 Significant premium to book - investor willingness to pay for intangible assets, brand, and growth.
EV/Revenue 1.09 Modest revenue multiple, common in consumer electronics/handset manufacturing.
EV/EBITDA 16.75 Indicates valuation on near-term operating profitability; higher than value stocks, lower than hype premium.
Market Cap ¥79.44 billion Equity market size at reported share price.
Share Price (12-Dec-2025) ¥69.01 Reference closing price for market-cap calculation.
Beta 1.02 Market-correlated volatility.
Valuation context: the TTM vs forward P/E spread (19.38 → 12.85) implies analysts expect material earnings improvement; combined with a P/B of 4.10 and EV/EBITDA of 16.75, the market is pricing both near-term profitability recovery and a premium for intangible or growth drivers. For additional company background and strategic context, see Shenzhen Transsion Holdings Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) - Risk Factors

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) faces a set of measurable risks in the near term, driven by sharply deteriorating top-line and profitability metrics in Q1 2025 and weakened operating cash generation.

Key headline metrics (Q1 2025 vs Q1 2024):

Metric Q1 2025 Q1 2024 YoY Change
Revenue change -25.45% - -25.45 pp
Net income 0.49 billion yuan (implied higher in 2024) -69.87%
Net profit margin 3.77% 12.65% -8.88 pp
Gross margin 19.97% (prior period higher) Pressure indicated
Net cash flow from operations -0.741 billion yuan -0.108 billion yuan worsened by 0.633 billion yuan
Total debt-to-equity ratio 13.64 - Moderate leverage
  • Revenue risk: A 25.45% decline in Q1 2025 revenue vs Q1 2024 signals difficulty sustaining sales momentum and potential market share loss in competitive segments.
  • Profitability risk: Net income fell 69.87% to 0.49 billion yuan, with net profit margin compressing from 12.65% to 3.77%, increasing vulnerability to minor revenue shortfalls or cost shocks.
  • Margin pressure: Gross margin at 19.97% indicates squeezed product-level profitability, likely from heightened competition and rising supply chain costs.

Cash flow and balance sheet concerns:

  • Operating cash flow deterioration: Net cash from operations deteriorated to -0.741 billion yuan in Q1 2025 from -0.108 billion yuan in Q1 2024, reducing internal funding for capex, marketing, or working capital.
  • Leverage: A total debt-to-equity ratio of 13.64 denotes a moderate leverage position; while not excessively high, combined with poor cash flow it can constrain financial flexibility.

Operational and market downside scenarios investors should monitor:

  • Continued revenue declines or slower-than-expected recovery, further pressuring margins and earnings.
  • Worsening working capital needs or higher supplier costs that exacerbate negative operating cash flow.
  • Competitive pressure in core markets leading to increased discounting or marketing spend to defend volumes.
  • External macro risks (currency, trade, component shortages) that magnify margin compression.

For background on the company's strategy, ownership and historical context that inform these risk dynamics see: Shenzhen Transsion Holdings Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) - Growth Opportunities

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) presents several identifiable growth levers underpinned by projected top-line and profitability expansion, geographic penetration, multi-brand segmentation, and sustained R&D investment.
  • Analyst projections: revenue of 77.5 billion yuan in 2025 and 87.2 billion yuan in 2026; net profit attributable to parent of 6.4 billion yuan in 2025 and 7.5 billion yuan in 2026.
  • Market sentiment: 26 buy recommendations and 2 hold recommendations from analysts, reflecting broadly positive expectations for execution and market traction.
  • R&D commitment: R&D expenses of 0.58 billion yuan in Q1 2025, supporting sustained product development and feature differentiation.
Metric 2025 (Projected) 2026 (Projected)
Revenue (CNY) 77.5 billion 87.2 billion
Net Profit Attributable to Parent (CNY) 6.4 billion 7.5 billion
Q1 2025 R&D Expense (CNY) 0.58 billion
Analyst Ratings 26 Buys, 2 Holds
Key strategic growth vectors include:
  • Multi-brand portfolio: targeted brands for entry-level, mid-range and premium segments to increase wallet share across diverse consumer cohorts.
  • Localized product and go-to-market adaptations: tailoring hardware, software and after-sales to regional preferences and network conditions to improve conversion and retention.
  • Emerging market expansion: deepening distribution and service networks in Africa and South Asia where smartphone penetration and replacement cycles remain under-optimized.
  • Product innovation pipeline: continued R&D spend to enhance camera, battery, software optimization and cost-performance, enabling differentiated value propositions versus global peers.
Financial and operational implications for investors:
  • Top-line growth to 87.2 billion yuan in 2026 implies a compound annual increase from 2024-2026 consistent with aggressive market share gains in targeted regions.
  • Net margin trajectory implied by 6.4-7.5 billion yuan net profit suggests improving profitability likely driven by scale, mix uplift from higher-tier models, and operational efficiencies.
  • R&D cadence (0.58 billion yuan in Q1 2025) signals sustained capex for product cycles; investors should monitor R&D-to-revenue ratio and time-to-market of new models.
  • Analyst consensus (26 buys, 2 holds) provides a near-term sentiment anchor but should be weighed against execution risks in supply chain, currency exposure, and competitive dynamics in target markets.
For more background on the company's origins, structure and business model, see: Shenzhen Transsion Holdings Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

DCF model

Shenzhen Transsion Holdings Co., Ltd. (688036.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.